Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |